Efficacy, cost, and aspects to take into account in the treatment of osteoporosis in the elderly.
作者： Pilar Sáez-López , Iñigo Etxebarria-Foronda , Maria Pilar Mesa Lampre , Noelia Alonso García , Natalia Sánchez Hernández
DOI: 10.1016/J.REGG.2018.11.007
关键词: Population 、 Osteoporosis 、 Gerontology 、 Incidence (epidemiology) 、 Fracture risk 、 Population pyramid 、 Medicine
摘要: Age is one of the principal risk factors for development frailty fractures. pyramids show a population that becoming increasingly more elderly, with an increasing incidence fractures, and forecasts future are truly alarming. Adequate handling these patients who especially at risk, both preventive care levels, well-defined orthogeriatric model necessary to respond this clinical challenge. The objective review analyze efficacy different strategies geriatric fracture risk.
elsevier.es参考文章(145)
Henry G Bone, Rachel B Wagman, Maria L Brandi, Jacques P Brown, Roland Chapurlat, Steven R Cummings, Edward Czerwiński, Astrid Fahrleitner-Pammer, David L Kendler, Kurt Lippuner, Jean-Yves Reginster, Christian Roux, Jorge Malouf, Michelle N Bradley, Nadia S Daizadeh, Andrea Wang, Paula Dakin, Nicola Pannacciulli, David W Dempster, Socrates Papapoulos, 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension The Lancet Diabetes & Endocrinology. ,vol. 5, pp. 513- 523 ,(2017) , 10.1016/S2213-8587(17)30138-9
D. Zeldow, E. Lewiecki, R. Adler, HIP FRACTURES AND DECLINING DXA TESTING: AT A BREAKING POINT? Innovation in Aging. ,vol. 1, pp. 843- 843 ,(2017) , 10.1093/GERONI/IGX004.3036
C Reyes, Cristian Tebe, D Martinez-Laguna, MS Ali, A Soria-Castro, C Carbonell, D Prieto-Alhambra, One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study. Osteoporosis International. ,vol. 28, pp. 2997- 3004 ,(2017) , 10.1007/S00198-017-4144-7
T. Saito, J. M. Sterbenz, S. Malay, L. Zhong, M. P. MacEachern, K. C. Chung, Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis. Osteoporosis International. ,vol. 28, pp. 3289- 3300 ,(2017) , 10.1007/S00198-017-4175-0
David L Kendler, Fernando Marin, Cristiano A F Zerbini, Luis A Russo, Susan L Greenspan, Vit Zikan, Alicia Bagur, Jorge Malouf-Sierra, Péter Lakatos, Astrid Fahrleitner-Pammer, Eric Lespessailles, Salvatore Minisola, Jean Jacques Body, Piet Geusens, Rüdiger Möricke, Pedro López-Romero, Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. The Lancet. ,vol. 391, pp. 230- 240 ,(2017) , 10.1016/S0140-6736(17)32137-2
Jia-Guo Zhao, Xian-Tie Zeng, Jia Wang, Lin Liu, Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis JAMA. ,vol. 318, pp. 2466- 2482 ,(2017) , 10.1001/JAMA.2017.19344
Paige Morizio, Jena I. Burkhart, Sachiko Ozawa, Denosumab: A Unique Perspective on Adherence and Cost-effectiveness Compared With Oral Bisphosphonates in Osteoporosis Patients. Annals of Pharmacotherapy. ,vol. 52, pp. 1031- 1041 ,(2018) , 10.1177/1060028018768808
Acute effect of anti-osteoporotic therapies on bone turnover markers in recent vertebral compression fractures European congress on osteoporosis and osteoarthritis (ESCEO13-IOF). ,vol. 24, ,(2013) , 10.1007/S00198-013-2312-Y
K. Lippuner, O. Torring, S. Minisola, C.L. Benhamou, S. Papapoulos, M.R. Mcclung, N. Daizadeh, H.G. Bone, R.B. Wagman, Z. Man, J.D. Adachi, J. Farrerons, A. Wang, J. Halse, N. Franchimont, S. Boonen, J.C. Gallagher, DENOSUMAB (DMAB) TREATMENT FOR 6 YEARS MAINTAINS LOW FRACTURE INCIDENCE IN WOMEN >= 75 YEARS WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO) ,vol. 24, ,(2013)
Blain H, Masud T, Dargent-Molina P, Martin FC, Rosendahl E, van der Velde N, Bousquet J, Benetos A, Cooper C, Kanis JA, Reginster JY, Rizzoli R, Cortet B, Barbagallo M, Dreinhöfer KE, Vellas B, None, A comprehensive fracture prevention strategy in older adults: the European Union Geriatric Medicine Society (EUGMS) statement Aging Clinical and Experimental Research. ,vol. 28, pp. 797- 803 ,(2016) , 10.1007/S40520-016-0588-4